Tongmai Yangxin Wan for atrial arrhythmias of coronary heart disease: a clinical study
Di Jie
Liu Liang
Huang Shaohua
Xu Qiaoling
Chen Yawei
Zhang Xinxin
Yuan Zegang
Xu Qian
Abstract：Objective To observe the curative effect of Tongmai Yangxin Wan on atrial arrhythmias of coronary heart disease (CHD). Methods The patients (n=120) were chosen from Department of Cardiology of the First Central Hospital of Baoding City in Hebei Province from Jan. 2015 to Jan. 2018, and then divided randomly into study group and control group (each n=60). The control group was given routine treatment and study group was additionally given Tongmai Yangxin Wan for 4 weeks as a course of treatment. The clinical efficacy, times and duration of arrhythmias attack and 6-minute walk distance (6MWD) were compared, and adverse reactions were recorded in 2 groups. Results After treatment, the total effective rate was 80.0% in study group, which was significantly higher than that in control group (56.7%). The times and duration of arrhythmias attack and 6MWD were superior in study group to those in control group (P＜0.05). There were no adverse reactions observed in 2 groups. Conclusion Tongmai Yangxin Wan can effectively relieve the clinical symptoms and improve exercise tolerance in patients with atrial arrhythmias of CHD, and it is worthy of clinic application.
Keywords：Tongmai Yangxin WanCoronary heart diseaseArrhythmiaCurative effect
Publication Date：2019-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 856-858 )